Robert McGreevy Daily Caller
The U.S. Department of Health and Human Services (HHS) intends to stop the Centers for Disease Control’s (CDC) recommendations that pregnant women, teenagers and children receive the COVID-19 vaccines, according to a Thursday report.
HHS will remove the CDC’s recommendations for those individuals “as a matter of routine,” people familiar told The Wall Street Journal (WSJ).
The announcement is “expected in the coming days,” sources told WSJ.
At the time of publication, the CDC’s website states that everyone six months and older should get the COVID-19 vaccine.
HHS Secretary Robert F. Kennedy Jr. has long been a critic of both the COVID-19 vaccines and their approved use for children and pregnant women. (RELATED: Congress Joins RFK’s Crusade Against Big Pharma)
The Children’s Health Defense (CHD) petitioned the Food and Drug Administration (FDA) about emergency use authorization (EUA) for Pfizer’s COVID-19 vaccine for children aged five to 11-years-old.
Kennedy, the group’s then-chairman and chief legal counsel, signed CHD’s letter to the FDA.
“Yes, we will take legal action against FDA if the agency grants Emergency Use Authorization for Pfizer’s vaccine for children aged 5-11,” Kennedy tweeted in 2021.
Kennedy stated in government ethics documents that he had resigned from CHD, the AP reported in January.
“The CDC recommends THREE Pfizer Covid shots for babies by age 9 months. These shots are unsafe and ineffective, especially over the long term. And babies are at near-zero risk from Covid. So whose benefit is the CDC serving here?” Kennedy wrote in September 2024.
The only 2024-2025 formula COVID-19 vaccines with full FDA approval are Pfizer-BioNTech’s Comirnaty and Moderna’s SpikeVax, according to the FDA.
Those vaccines are approved for people 12 years and older, according to a FDA press release.
WSJ reported the potential move ahead of the administration’s plan to introduce a new framework for vaccine manufacturers.
FDA Commissioner Marty Makary announced plans to reshape agency guidance Thursday.
“We want to be very transparent, and we want to create a framework for vaccine makers that they can use so they have a predictable FDA where they don’t have to worry,” Makary announced at the Food and Drug Law Institute conference Thursday, according to Stat News.